AbbVie

Hospitals

Bristol Myers Squibb latest to roll out 340B restrictions

Bristol Myers Squibb became the 12th drugmaker, and second in the past month, to announce a policy for 340B contract pharmacy restrictions.
Robert King Jan 19, 2022 9:30am

AbbVie latest to impose 340B sales restrictions

Jan 5, 2022 9:30am

House Dems: 14 drugmakers spent $577B on buybacks, dividends

Jul 9, 2021 7:05am

Healthcare stocks rise following midterm election—roundup

Nov 9, 2018 12:05am

Questions about disclosures, studies bring down 2 researchers

Sep 20, 2018 1:05pm

Cigna expands its collaboration with Omada Health—roundup

Sep 19, 2018 8:39am